High risk of myelodysplastic syndrome and acute myeloid leukemia after 177Lu-octreotate PRRT in NET patients heavily pretreated with alkylating chemotherapy

被引：51

作者：

Brieau, Bertrand ^{[1
]}

Hentic, Olivia ^{[1
]}

Lebtahi, Rachida ^{[2
]}

Palazzo, Maxime ^{[1
]}

Ben Reguiga, Makrem ^{[3
]}

Rebours, Vinciane ^{[1
]}

Maire, Frederique ^{[1
]}

Hammel, Pascal ^{[1
]}

Ruszniewski, Philippe ^{[1
]}

Fenaux, Pierre ^{[4
]}

机构：

[1] Univ Paris Diderot, Hop Beaujon, AP HP, Serv Gastroenterol & Pancreatol, Clichy, France

[2] Univ Paris Diderot, Hop Beaujon, AP HP, Nucl Med Serv, Clichy, France

[3] Univ Paris Diderot, Hop Beaujon, AP HP, Dept Pharm, Clichy, France

[4] Univ Paris Diderot, Hop St Louis, AP HP, Serv Hematol, Paris, France

来源：

关键词：

RADIOLABELED SOMATOSTATIN ANALOG; RECEPTOR RADIONUCLIDE THERAPY; NEUROENDOCRINE TUMORS; SURVIVAL; TOXICITY; METASTASES; MIDGUT;

D O I：

10.1530/ERC-15-0543

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：L17 / L23

页数：7

共 11 条

[1]

Bergsma H, 2015, EUROPEAN J NUCL MED, V43, P453, DOI [10.1007/s00259-015-3193-4, DOI 10.1007/S00259-015-3193-4)]

[2] Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors [J].

Bodei, Lisa ;

Kidd, Mark ;

Paganelli, Giovanni ;

Grana, Chiara M. ;

Drozdov, Ignat ;

Cremonesi, Marta ;

Lepensky, Christopher ;

Kwekkeboom, Dik J. ;

Baum, Richard P. ;

Krenning, Eric P. ;

Modlin, Irvin M. .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (01) :5-19

[3] Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM) [J].

Della Porta, M. G. ;

Tuechler, H. ;

Malcovati, L. ;

Schanz, J. ;

Sanz, G. ;

Garcia-Manero, G. ;

Sole, F. ;

Bennett, J. M. ;

Bowen, D. ;

Fenaux, P. ;

Dreyfus, F. ;

Kantarjian, H. ;

Kuendgen, A. ;

Levis, A. ;

Cermak, J. ;

Fonatsch, C. ;

Le Beau, M. M. ;

Slovak, M. L. ;

Krieger, O. ;

Luebbert, M. ;

Maciejewski, J. ;

Magalhaes, S. M. M. ;

Miyazaki, Y. ;

Pfeilstoecker, M. ;

Sekeres, M. A. ;

Sperr, W. R. ;

Stauder, R. ;

Tauro, S. ;

Valent, P. ;

Vallespi, T. ;

van de Loosdrecht, A. A. ;

Germing, U. ;

Haase, D. ;

Greenberg, P. L. ;

Cazzola, M. .

LEUKEMIA, 2015, 29 (07) :1502-1513

[4] Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [90Y-DOTA]-TOC in Metastasized Neuroendocrine Cancers [J].

Imhof, Anna ;

Brunner, Philippe ;

Marincek, Nicolas ;

Briel, Matthias ;

Schindler, Christian ;

Rasch, Helmut ;

Maecke, Helmut R. ;

Rochlitz, Christoph ;

Mueller-Brand, Jan ;

Walter, Martin A. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (17) :2416-2423

[5] Hematological Toxicity of Combined 177Lu-Octreotate Radiopeptide Chemotherapy of Gastroenteropancreatic Neuroendocrine Tumors in Long-Term Follow-Up [J].

Kesavan, Murali ;

Claringbold, Phillip G. ;

Turner, J. Harvey .

NEUROENDOCRINOLOGY, 2014, 99 (02) :108-117

[6] Treatment with the radiolabeled somatostatin analog [177Lu-DOTA0, Tyr3] octreotate:: Toxicity, efficacy, and survival [J].

Kwekkeboom, Dik J. ;

de Herder, Wouter W. ;

Kam, Boen L. ;

van Eijck, Casper H. ;

van Essen, Martijn ;

Kooij, Peter P. ;

Feelders, Richard A. ;

van Aken, Maarten O. ;

Krenning, Eric P. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (13) :2124-2130

[7] [177Lu-DOTA0,Tyr3]octreotate:: comparison with [111In-DTPA0]octreotide in patients [J].

Kwekkeboom, DJ ;

Bakker, WH ;

Kooij, PPM ;

Konijnenberg, MW ;

Srinivasan, A ;

Erion, JL ;

Schmidt, MA ;

Bugaj, JL ;

de Jong, M ;

Krenning, EP .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (09) :1319-1325

[8] ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary [J].

Pavel, Marianne ;

Baudin, Eric ;

Couvelard, Anne ;

Krenning, Eric ;

Oberg, Kjell ;

Steinmueller, Thomas ;

Anlauf, Martin ;

Wiedenmann, Bertram ;

Salazar, Ramon .

NEUROENDOCRINOLOGY, 2012, 95 (02) :157-176

[9] Can peptide receptor radionuclide therapy be safely applied in florid bone metastases? A pilot analysis of late stage osseous involvement [J].

Sabet, A. ;

Khalaf, F. ;

Yong-Hing, C. J. ;

Haslerud, T. ;

Ahmadzadehfar, H. ;

Guhlke, S. ;

Gruenwald, F. ;

Biersack, H. -J. ;

Ezziddin, S. .

NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2014, 53 (02) :54-59

[10] Long-Term Hematotoxicity After Peptide Receptor Radionuclide Therapy with 177Lu-Octreotate [J].

Sabet, Amir ;

Ezziddin, Khaled ;

Pape, Ulrich-Frank ;

Ahmadzadehfar, Hojjat ;

Mayer, Karin ;

Poeppel, Thorsten ;

Guhlke, Stefan ;

Biersack, Hans-Juergen ;

Ezziddin, Samer .

JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (11) :1857-1861

← 1 2 →